![Stephen W. Potter](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Stephen W. Potter
Corporate Officer/Principal at
APPLIED GENETIC TECHNOLOGIES CORPORATION
Profile
Stephen W.
Potter currently works at Beacon Therapeutics (USA), Inc., as Chief Business Officer & Vice President from 2015.
Mr. Potter also formerly worked at Osiris Therapeutics, Inc., as SVP-Operations & Corporate Development from 2011 to 2012, Genzyme Corp., as Senior VP-Corporate & Business Development from 2006 to 2010, NeoStem, Inc., as Executive Vice President from 2013 to 2015, and Caladrius Biosciences, Inc., as Executive Vice President from 2013 to 2015.
Mr. Potter received his undergraduate degree in 1979 from the University of Massachusetts and Masters Business Admin degree from Harvard Business School.
Stephen W. Potter active positions
| Companies | Position | Start |
|---|---|---|
| APPLIED GENETIC TECHNOLOGIES CORPORATION | Corporate Officer/Principal | 01/01/2015 |
Former positions of Stephen W. Potter
| Companies | Position | End |
|---|---|---|
Caladrius Biosciences, Inc.
 Caladrius Biosciences, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops and commercializes cellular therapies products | Director/Board Member | 30/07/2013 |
NeoStem, Inc. /Old/
 NeoStem, Inc. /Old/ Other TransportationTransportation Operates a commercial autologous adult stem cell bank | Director/Board Member | 01/07/2013 |
| OSIRIS THERAPEUTICS, INC. | Chief Operating Officer | 01/11/2012 |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Corporate Officer/Principal | 01/01/2010 |
Training of Stephen W. Potter
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
80
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Osiris Therapeutics, Inc.
 Osiris Therapeutics, Inc. BiotechnologyHealth Technology Researches and develops therapeutic products for the regeneration of human connective tissues | Health Technology |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
University of Massachusetts
 University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Beacon Therapeutics (USA), Inc.
 Beacon Therapeutics (USA), Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical research and development company that provides gene therapy development & clinical research services | Health Technology |
NeoStem, Inc. /Old/
NeoStem, Inc. /Old/ Other TransportationTransportation Operates a commercial autologous adult stem cell bank | Transportation |
Caladrius Biosciences, Inc.
Caladrius Biosciences, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops and commercializes cellular therapies products | Health Technology |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Stephen W. Potter
